“Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated With Thrombopoietin Receptor Agonists”. Mediterranean Journal of Hematology and Infectious Diseases 15, no. 1 (February 28, 2023): e2023021. Accessed May 10, 2026. https://www.mjhid.org/mjhid/article/view/5240.